Perimeter Medical Imaging AI, Inc.
Financial Statements (IFRS) · Amounts in CAD
Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 536,100 | 505,796 | 550,269 | 293,133 | 208,420 | -- |
| Operating Revenue | 536,100 | 505,796 | 281,082 | 293,133 | 208,420 | -- |
| Cost Of Revenue | 264,694 | 152,941 | 250,892 | 104,268 | 81,333 | -- |
| Gross Profit | 271,406 | 352,855 | 299,377 | 188,865 | 127,087 | -- |
| Selling General And Administration | 1.9M | 2.6M | 2.9M | 2.6M | 2.9M | -- |
| General And Administrative Expense | 1.1M | 1.6M | 1.7M | 1.2M | 1.6M | -- |
| Research And Development | 1.0M | 1.5M | 1.6M | 1.9M | 1.5M | -- |
| Depreciation And Amortization In Income Statement | 108,052 | 115,974 | 119,645 | 131,605 | 131,829 | -- |
| Other Operating Expenses | -- | -- | -- | -107,998 | -12,259 | -12,259 |
| Operating Expense | 3.0M | 4.3M | 4.6M | 4.5M | 4.5M | -- |
| Operating Income | -2.7M | -3.9M | -4.3M | -4.4M | -4.4M | -- |
| EBIT | -2.7M | -3.9M | -4.3M | -3.4M | -4.7M | -- |
| Interest Expense | 4,452 | 4,978 | 5,800 | 5,448 | 5,909 | -- |
| Interest Expense Non Operating | 4,452 | 4,978 | 5,800 | 5,448 | 5,909 | -- |
| Net Interest Income | 234.00 | -4,617 | 26,513 | 63,717 | 21,833 | -- |
| Other Income Expense | 8,562 | 28,371 | -4,800 | 870,405 | -289,843 | -- |
| Gain On Sale Of Security | 8,562 | 28,371 | -4,800 | 870,405 | -289,843 | -- |
| Pretax Income | -2.7M | -3.9M | -4.3M | -3.4M | -4.7M | -- |
| Tax Provision | 0.00 | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | -2.7M | -3.9M | -4.3M | -3.4M | -4.7M | -- |
| Net Income From Continuing Operation Net Minority Interest | -2.7M | -3.9M | -4.3M | -3.4M | -4.7M | -- |
| Net Income Including Noncontrolling Interests | -2.7M | -3.9M | -4.3M | -3.4M | -4.7M | -- |
| Net Income Common Stockholders | -2.7M | -3.9M | -4.3M | -3.4M | -4.7M | -- |
| Net Income | -2.7M | -3.9M | -4.3M | -3.4M | -4.7M | -- |
| EBITDA | -2.5M | -3.7M | -4.1M | -3.2M | -4.5M | -- |
| Normalized EBITDA | -2.5M | -3.7M | -4.1M | -4.1M | -4.2M | -- |
| Reconciled Depreciation | 207,697 | 207,701 | 207,413 | 210,870 | 188,964 | -- |
| Basic EPS | 0.03 | -0.04 | -0.05 | -- | -0.07 | -0.05 |
| Diluted EPS | 0.03 | -0.04 | -0.05 | -- | -0.07 | -0.05 |
| Basic Average Shares | 102.3M | 96.6M | 93.5M | -- | 65.1M | 65.1M |
| Diluted Average Shares | 102.3M | 96.6M | 93.5M | -- | 65.1M | 65.1M |
| Total Unusual Items | 8,562 | 28,371 | -4,800 | 870,405 | -289,843 | -- |
| Total Unusual Items Excluding Goodwill | 8,562 | 28,371 | -4,800 | 870,405 | -289,843 | -- |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Normalized Income | -2.7M | -3.9M | -4.3M | -4.3M | -4.4M | -- |
| Depreciation Amortization Depletion Income Statement | 108,052 | 115,974 | 119,645 | 131,605 | 131,829 | -- |
| Depreciation Income Statement | 108,052 | 115,974 | 119,645 | 131,605 | 131,829 | -- |
| Diluted NI Availto Com Stockholders | -2.7M | -3.9M | -4.3M | -3.4M | -4.7M | -- |
| Net Income Continuous Operations | -2.7M | -3.9M | -4.3M | -3.4M | -4.7M | -- |
| Net Non Operating Interest Income Expense | 234.00 | -4,617 | 26,513 | 63,717 | 21,833 | -- |
| Other Gand A | 1.1M | 1.6M | 1.7M | 1.2M | 1.6M | -- |
| Reconciled Cost Of Revenue | 165,049 | 61,214 | 163,124 | 25,003 | 24,198 | -- |
| Selling And Marketing Expense | 780,134 | 1.0M | 1.3M | 1.4M | 1.2M | -- |
| Total Expenses | 3.3M | 4.4M | 4.9M | 4.6M | 4.6M | -- |
| Total Other Finance Cost | -4,686 | -361.00 | -32,313 | -69,165 | -27,742 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 1.7M | 1.4M | 2.4M | 6.2M | 9.5M | -- |
| Cash Cash Equivalents And Short Term Investments | 1.7M | 1.4M | 2.4M | 6.2M | 9.5M | -- |
| Cash Financial | 1.7M | 1.4M | 2.4M | -- | 9.5M | 6.5M |
| Accounts Receivable | 96,675 | 221,485 | 477,116 | 390,525 | 223,281 | -- |
| Receivables | 129,073 | 1.0M | 1.4M | 2.4M | 2.2M | -- |
| Inventory | 78,554 | 116,599 | 198,730 | 191,577 | 32,425 | -- |
| Prepaid Assets | 613,525 | 570,790 | 494,272 | 1.2M | 1.2M | -- |
| Current Assets | 2.5M | 3.1M | 4.5M | 10.0M | 12.9M | -- |
| Gross PPE | 6.3M | 6.4M | 6.4M | 6.5M | 4.7M | -- |
| Accumulated Depreciation | -2.8M | -2.6M | -2.4M | -2.1M | -1.9M | -- |
| Net PPE | 3.5M | 3.8M | 4.0M | 4.4M | 2.8M | -- |
| Other Non Current Assets | -- | 1.00 | -- | 1.00 | -- | -- |
| Total Non Current Assets | 3.5M | 3.8M | 4.0M | 4.4M | 2.8M | -- |
| Total Assets | 6.0M | 6.9M | 8.6M | 14.3M | 15.7M | -- |
| Current Debt And Capital Lease Obligation | 34,787 | 41,794 | 45,262 | 46,813 | 49,800 | -- |
| Payables And Accrued Expenses | 1.7M | 1.6M | 1.5M | 3.3M | 2.0M | -- |
| Current Deferred Revenue | 324,349 | 307,865 | 203,324 | 144,226 | 144,895 | -- |
| Other Current Liabilities | 2,194 | 4,975 | 50,640 | 53,182 | 438,509 | -- |
| Current Liabilities | 2.1M | 1.9M | 1.8M | 3.6M | 2.6M | -- |
| Long Term Debt And Capital Lease Obligation | 66,968 | 75,252 | 80,493 | 90,671 | 106,631 | -- |
| Long Term Capital Lease Obligation | 66,968 | 75,252 | 80,493 | 90,671 | 106,631 | -- |
| Total Non Current Liabilities Net Minority Interest | 434,017 | 481,992 | 262,686 | 296,232 | 274,666 | -- |
| Total Liabilities Net Minority Interest | 2.5M | 2.4M | 2.1M | 3.9M | 2.9M | -- |
| Common Stock | 92.5M | 91.6M | 90.6M | 90.6M | 89.0M | -- |
| Capital Stock | 92.5M | 91.6M | 90.6M | 90.6M | 89.0M | -- |
| Additional Paid In Capital | 11.4M | 10.6M | 9.7M | 9.4M | 9.4M | -- |
| Retained Earnings | -97.7M | -95.0M | -91.1M | -86.8M | -83.3M | -- |
| Gains Losses Not Affecting Retained Earnings | -2.8M | -2.8M | -2.8M | -2.8M | -2.4M | -- |
| Common Stock Equity | 3.5M | 4.5M | 6.5M | 10.5M | 12.8M | -- |
| Stockholders Equity | 3.5M | 4.5M | 6.5M | 10.5M | 12.8M | -- |
| Total Equity Gross Minority Interest | 3.5M | 4.5M | 6.5M | 10.5M | 12.8M | -- |
| Total Capitalization | 3.5M | 4.5M | 6.5M | 10.5M | 12.8M | -- |
| Net Tangible Assets | 3.5M | 4.5M | 6.5M | 10.5M | 12.8M | -- |
| Tangible Book Value | 3.5M | 4.5M | 6.5M | 10.5M | 12.8M | -- |
| Working Capital | 433,061 | 1.2M | 2.7M | 6.4M | 10.3M | -- |
| Invested Capital | 3.5M | 4.5M | 6.5M | 10.5M | 12.8M | -- |
| Total Debt | 101,755 | 117,046 | 125,755 | 137,484 | 156,431 | -- |
| Share Issued | 111.4M | 103.9M | 93.5M | 93.5M | 88.5M | -- |
| Ordinary Shares Number | 111.4M | 103.9M | 93.5M | 93.5M | 88.5M | -- |
| Accrued Interest Receivable | 4,168 | 4,240 | 10,145 | 19,292 | 2,034 | -- |
| Capital Lease Obligations | 101,755 | 117,046 | 125,755 | 137,484 | 156,431 | -- |
| Construction In Progress | 1.5M | 1.7M | 1.7M | 2.1M | 384,585 | -- |
| Current Capital Lease Obligation | 34,787 | 41,794 | 45,262 | 46,813 | 49,800 | -- |
| Current Deferred Liabilities | 324,349 | 307,865 | 203,324 | 144,226 | 144,895 | -- |
| Foreign Currency Translation Adjustments | -2.8M | -2.8M | -2.8M | -2.8M | -2.4M | -- |
| Leases | 146,303 | 146,683 | 145,629 | 145,594 | 146,946 | -- |
| Machinery Furniture Equipment | 72,864 | 74,119 | 70,645 | 70,528 | 74,986 | -- |
| Non Current Deferred Liabilities | 367,049 | 406,740 | 182,193 | 205,561 | 168,035 | -- |
| Non Current Deferred Revenue | 367,049 | 406,740 | 182,193 | 205,561 | 168,035 | -- |
| Other Properties | 4.5M | 4.5M | 4.5M | 4.2M | 4.1M | -- |
| Other Receivables | -- | 744,684 | 884,302 | 1.9M | 1.9M | 1.8M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Taxes Receivable | 28,230 | 76,707 | 36,598 | 52,297 | 48,392 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.2M | -2.9M | -3.8M | -3.1M | -4.1M | -- |
| Cash Flow From Continuing Operating Activities | -1.2M | -2.9M | -3.8M | -3.1M | -4.1M | -- |
| Depreciation And Amortization | 207,697 | 207,701 | 207,413 | 210,870 | 188,964 | -- |
| Depreciation Amortization Depletion | 207,697 | 207,701 | 207,413 | 210,870 | 188,964 | -- |
| Stock Based Compensation | 183,071 | 60,713 | 326,610 | 87,689 | 484,559 | -- |
| Change In Working Capital | 1.3M | 629,431 | 25,418 | 1.1M | -248,691 | -- |
| Changes In Account Receivables | 124,810 | 255,631 | -86,591 | -167,244 | 34,327 | -- |
| Change In Receivables | 918,115 | 346,677 | 962,551 | -230,112 | 36,806 | -- |
| Change In Inventory | 294,435 | -46,064 | 121,042 | -159,152 | 28,885 | -- |
| Change In Payables And Accrued Expense | 137,583 | 76,248 | -1.8M | 1.4M | -342,697 | -- |
| Change In Other Working Capital | -23,207 | 329,088 | 35,730 | -315,204 | 66,077 | -- |
| Other Non Cash Items | -2,933 | -46,514 | -26,513 | 2.8M | 96,224 | -- |
| Capital Expenditure | -- | -- | -- | -1.8M | -128,195 | -- |
| Purchase Of PPE | 0.00 | -- | -- | -1.8M | -128,195 | -256,390 |
| Net PPE Purchase And Sale | 0.00 | -- | -- | -1.8M | -128,195 | -256,390 |
| Investing Cash Flow | 4,685 | 10,829 | 22,185 | -1.7M | -85,750 | -- |
| Cash Flow From Continuing Investing Activities | 4,685 | 10,829 | 22,185 | -1.7M | -85,750 | -- |
| Repayment Of Debt | -17,813 | -18,236 | -18,210 | -18,430 | -17,797 | -- |
| Net Issuance Payments Of Debt | -17,813 | -18,236 | -18,210 | -18,430 | -17,797 | -- |
| Issuance Of Capital Stock | 1.5M | -- | -- | 1.4M | 7.2M | -- |
| Net Common Stock Issuance | 1.5M | -- | -- | 1.4M | 7.2M | -- |
| Financing Cash Flow | 1.5M | 1.8M | -18,210 | 1.4M | 7.2M | -- |
| Cash Flow From Continuing Financing Activities | 1.5M | 1.8M | -18,210 | 1.4M | 7.2M | -- |
| Effect Of Exchange Rate Changes | -14,465 | -46,387 | 24,306 | 117,995 | -682.00 | -- |
| Changes In Cash | 335,755 | -1.0M | -3.8M | -3.5M | 3.0M | -- |
| Beginning Cash Position | 1.4M | 2.4M | 6.2M | 9.5M | 6.5M | -- |
| End Cash Position | 1.7M | 1.4M | 2.4M | 6.2M | 9.5M | -- |
| Free Cash Flow | -1.2M | -2.9M | -3.8M | -4.9M | -4.2M | -- |
| Change In Prepaid Assets | -42,735 | -76,518 | 737,369 | 390,630 | -37,762 | -- |
| Common Stock Issuance | 1.5M | -- | -- | 1.4M | 7.2M | -- |
| Depreciation | -- | 207,701 | 207,413 | -- | -- | 174,631 |
| Gain Loss On Investment Securities | -- | -- | -2,627 | -- | -- | -- |
| Gain Loss On Sale Of PPE | -128,195 | -- | -- | 0.00 | 42,646 | 0.00 |
| Interest Received Cfi | 4,685 | 10,829 | 22,185 | 51,907 | 42,445 | -- |
| Long Term Debt Payments | -17,813 | -18,236 | -18,210 | -18,430 | -17,797 | -- |
| Net Foreign Currency Exchange Gain Loss | -12,264 | 37,933 | 8,520 | -552,315 | 41,366 | -- |
| Net Income From Continuing Operations | -2.7M | -3.9M | -4.3M | -3.4M | -4.7M | -- |
| Net Long Term Debt Issuance | -17,813 | -18,236 | -18,210 | -18,430 | -17,797 | -- |
| Operating Gains Losses | -140,459 | 168,755 | 5,893 | -3.8M | 84,012 | -- |
| Proceeds From Stock Option Exercised | 0.00 | -- | -- | 58.00 | -1.00 | 19.00 |